Lastly, Slamova et al. 178 developed a mouse strain with transgenic expression of human Ser52Pro TTR that can form significant amyloid deposits in the heart and tongue after 4–11 months, achieved by seeding with amyloid extracted from a Ser52Pro ATTR amyloidosis patient. This evidence concerns the gene TTR and amyloidosis.